IDEAS home Printed from https://ideas.repec.org/a/pal/easeco/v36y2010i2p239-254.html
   My bibliography  Save this article

Who Pays for Drug Quality?

Author

Listed:
  • Jie Chen

    (Department of Political Science, Economics, and Philosophy, College of Staten Island/City University of New York, 2800 Victory Blvd, Room 2N 229, Staten Island, NY 10314, USA.)

  • John A Rizzo

    (Department of Economics and Department of Preventive Medicine, Stony Brook University, Stony Brook, NY 11794, USA.)

Abstract

This study examines how pharmaceutical costs for higher quality drugs are shared between insurers and consumers. Who bears these costs has important implications for patient access to better drugs, and for differences in access to higher quality pharmaceuticals. We investigate these issues using data from two large drug product classes: non-steroidal anti-inflammatory drugs (NSAIDs) and antidepressants. We find that insurers shift the drug costs associated with higher quality onto consumers for antidepressants but share in the costs of higher quality for NSAIDs. This suggests that patients’ cost burden, hence access, to higher quality drugs may vary across drug product classes.

Suggested Citation

  • Jie Chen & John A Rizzo, 2010. "Who Pays for Drug Quality?," Eastern Economic Journal, Palgrave Macmillan;Eastern Economic Association, vol. 36(2), pages 239-254, Spring.
    • Handle: RePEc:pal:easeco:v:36:y:2010:i:2:p:239-254
    as

    Download full text from publisher

    File URL: http://www.palgrave-journals.com/eej/journal/v36/n2/pdf/eej20098a.pdf
    File Function: Link to full text PDF
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: http://www.palgrave-journals.com/eej/journal/v36/n2/full/eej20098a.html
    File Function: Link to full text HTML
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fossett, Sarah J. & Wunnava, Phanindra V., 2017. "Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs," IZA Discussion Papers 10817, Institute of Labor Economics (IZA).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:easeco:v:36:y:2010:i:2:p:239-254. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave-journals.com/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.